|
Abstract
USC researchers have developed a novel prodrug platform that address all three issues with ANP antivirals. Using this technology, they have synthesized prodrugs of cidofovir and related ANP antivirals that are much more potent that the parent drugs in vitro, show 10x higher oral bioavailability, and have promise of better safety profiles....
|